Deep 6 AI is a fast-growing tech startup founded in 2016, on a mission to bring life-saving treatments to patients faster with AI in clinical trials. Their Precision Research Ecosystem connects researchers, physicians, sponsors, and CROs to advance research faster than the speed of disease.

Deep 6 AI disrupts the clinical trial enrollment process by transforming the way researchers identify eligible patients. Using artificial intelligence and natural language processing to mine structured and unstructured patient data, DEEP 6 AI finds more, better-matching patients for trials in minutes, not months.

Deep 6 AI works with some of the most prominent health systems, pharma companies, and CROs in the world --making the DEEP 6 platform a crucial step in their clinical research workflow and greatly accelerating patients’ access to clinical trials. 

DEEP 6 AI was founded in 2015 and is based in Pasadena, CA.


Techstars

Cedars-Sinai Accelerator

Brooks Hill Partners

Point72 Ventures

GSR Ventures

Iaso Ventures

Summation Health Ventures

Deep 6 AI

Thank you Marjorie Zettler, PhD, MPH at Accutar Biotech for moderating today's panel: Using RWD to Increase Patient Diversity in Clinical Trials. There were many takeaways including Deep 6 AI's CEO, Wout Brusselaers' perspective:

Too often, PIs at academic medical centers do not have diverse patient panels. Having PIs focus on recruiting patients from their panel is one of the biggest blockers to improving diversity in clinical trials. By leveraging #AI to mine #EMR data across a health system's entire network we can find eligible patients seen by physicians at sites in underserved communities. And we can allow physicians treating diverse patients to see which trials their patients are eligible for in their EMR and refer them to a PI within their network.

Dyan Bryson
Jen Banks, MA, MA, PMP
Barry C. Leybovich


Deep 6 AI's CEO, Wout Brusselaers, is at #SCOPEsummit discussing how sponsors have accelerated recruitment and generated RWE faster with our #AI-powered patient matching software and deep, real-time #EMR data.

Our CEO, Wout Brusselaers, is presenting today at 4:10 pm in the RWE track at #SCOPEsummit. Come hear case studies about sponsors that have accelerated patient recruitment with #AI.

Start your morning right with an espresso drink ☕ at booth #1035.

Timothy Keliher, John Harvey, Melissa Collins, Antonia Holway, Allison McKinley, Daniel Calvert, Wout Brusselaers.

#SCOPEsummit

AI:DEEP6

Deep 6 AI

Analysis Not Available